The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. In some embodiments, the present invention provides an antibody having a heavy chain with an amino acid sequence comprising at least 95% sequence identity to SEQ ID NO: 63 and having a light chain with an amino acid sequence comprising at least 95% sequence identity to SEQ ID NO: 64.
申请公布号
WO2016057916(A1)
申请公布日期
2016.04.14
申请号
WO2015US54936
申请日期
2015.10.09
申请人
SIAMAB THERAPEUTICS, INC.
发明人
DA SILVA, ANA PAULA GALVAO;DESANDER, JULIE;BEHRENS, JEFFREY;GHADERI, DARIUS;ZHANG, MAI;MEETZE, KRISTAN